PRKCI and familial pancreatic carcinoma: demonstrated that PKCι triggers the apoptosis and progress of pancreatic cancer cells by activating AKT and Wnt/β-catenin signaling pathways, which provides a potential therapeutic target for the treatment of pancreatic cancer (46).